Kidney health may change how drug works in body

NCT ID NCT06589713

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at how different levels of kidney function affect the way the drug enpatoran moves through the body. 34 adults with normal or impaired kidney function received a single dose of enpatoran. Researchers measured drug levels in the blood and monitored for side effects to understand if kidney problems change how the drug is processed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

enpatoran

What this could lead to

If successful, this study could help doctors determine the right dose of enpatoran for people with kidney problems, making the drug safer and more effective.

What could go wrong

This is an early-phase study with only 34 participants, focused on drug levels and safety, not on treating a disease. Results may not apply to all patients or lead to a treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease impaired renal function disease kidney failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CRS Clinical Research Services Kiel GmbH

    Kiel, Schleswig-Holstein, 24105, Germany